Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, targeted short-interfering RNA (siRNA) ...
The market may attempt a rebound after the four-day loss, but sustainability will be key. Below are some trading ideas for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果